Overview

Efficacy and Safety of Eschscholtzia Californica in Treating Primary Insomnia

Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The aim of this trial was to assess the efficacy and safety of Eschscholtzia Californica (EC) in treating patients having psycho-physiologic insomnia in a double-blind randomised placebo controlled trial during a 28-day treatment duration.
Phase:
Phase 3
Details
Lead Sponsor:
Boehringer Ingelheim